Health
BioVaxys Files Patent Application for Novel COVID-19 Diagnostic for T-Cell Immunity – MENAFN.COM
BioVaxys Files Patent Application for Novel COVID-19 Diagnostic for T-Cell ImmunityVancouver, British Columbia–(Newsfile Corp. – November 2, 2020) – BioVaxys Technology…
(MENAFN – Newsfile Corp) BioVaxys Files Patent Application for Novel COVID-19 Diagnostic for T-Cell Immunity
Vancouver, British Columbia–(Newsfile Corp. – November 2, 2020) – BioVaxys Technology Corp. (CSE: BIOV) (“BioVaxys” or “the Company”), a world leader in haptenized protein vaccine research and development, announced today that it has filed a Provisional Patent Application with the U.S. Patent and Trademark Office entitled METHOD AND KIT FOR DETECTION OF CELL MEDIATED IMMUNE RESPONSE related…
-
General22 hours agoMan charged with murder after alleged assault victim dies in Hervey Bay
-
General17 hours agoTaylor Swift breaks Adele’s record for most album sales in first week
-
Noosa News21 hours agoPublic health alert for nitazenes issued after person dies in Queensland
-
Business20 hours agoWhat’s Macquarie’s price target on Mineral Resources shares?